Counterpoint Mutual Funds’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.37M Buy
529,866
+497,145
+1,519% +$7.76M 0.73% 29
2026
Q1
$412K Buy
+32,721
New +$332K 0.06% 187
2025
Q4
Sell
-39,556
Closed -$371K 347
2025
Q3
$371K Buy
39,556
+722
+2% +$6.73K 0.03% 229
2025
Q2
$348K Sell
38,834
-192,850
-83% -$1.54M 0.03% 225
2025
Q1
$2.02M Buy
+231,684
New +$2.33M 0.29% 20
2024
Q1
Sell
-18,801
Closed -$138K 168
2023
Q4
$138K Buy
+18,801
New +$124K 0.05% 76

Other funds holding ADTN

Counterpoint Mutual Funds's ADTN Position: Q2 2026 in Review

Counterpoint Mutual Funds increased its Adtran (ADTN) stake by 1,519% in Q2 2026, buying an estimated $7.76M and bringing the position to 529,866 shares worth $7.37M. The position accounts for 0.73% of the portfolio, ranked #29.

Counterpoint Mutual Funds first reported a position in ADTN in Q4 2023 and has held it in 6 quarters since. 249 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • Counterpoint Mutual Funds held 529,866 shares of Adtran worth $7.37M as of Q2 2026.
  • Counterpoint Mutual Funds bought 497,145 Adtran shares in Q2 2026, an estimated $7.76M.
  • Adtran made up 0.73% of Counterpoint Mutual Funds's portfolio in Q2 2026, its #29 holding.
  • Counterpoint Mutual Funds first reported a position in Adtran in Q4 2023 and has held it in 6 quarters since.
  • 249 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2026, filed 20 Jul 2026.